Wed, Apr 23, 2014, 11:14 AM EDT - U.S. Markets close in 4 hrs 46 mins

Recent

% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • greatdayforinvestments greatdayforinvestments Jan 17, 2013 8:44 PM Flag

    Cowan Group recent comment: "We believe the focus on the institutional setting is the primary driver for the strong growth in Nuedexta scripts."

    Rx Growth Is Strong, Particularly In The LTC Segment:
    Avanir has expanded the institutional sales team to a total of 54 representatives who
    are calling on nursing homes only. Additionally, the retail sales team (comprised of
    72 representatives) are spending 30% of their time calling LTC facilities as well. We
    believe the focus on the institutional setting is the primary driver for the strong
    growth in Nuedexta scripts. Avanir expects all newly hired institutional sales
    representatives to become fully functional by year-end 2012. Therefore, we estimate
    that the uptake in scripts will continue to accelerate in the coming quarters.

    Sentiment: Strong Buy

 
AVNR
3.54-0.06(-1.67%)11:13 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.